Creutzfeldt-Jakob disease (CJD) alert over Nycomed Amersham imaging agent
This article was originally published in Clinica
Executive Summary
Nycomed Amersham in the UK has recalled a batch of its Amerscan Pulmonate II imaging agent, after discovering that it contained material from a donor suffering from new variant Creutzfeldt-Jakob disease.